logo
French Open: Tennis players wonder if nasal strips aren't just for snoring anymore

French Open: Tennis players wonder if nasal strips aren't just for snoring anymore

PARIS (AP) — If more tennis players find themselves breathing easier, it might just be thanks to Carlos Alcaraz.
The four-time Grand Slam champion, whose bid for a second consecutive French Open title was scheduled to continue with a third-round match Friday night, has often worn a nasal strip in matches since last season — although not during his first two contests at Roland-Garros this week — and the sport's other athletes took note.
After all, if Alcaraz finds something useful on the court, their thinking goes, maybe it makes sense to give the adhesive bands a shot.
'I saw Carlos playing in it,' said 18-year-old Mirra Andreeva, a semifinalist in Paris last year and the No. 6 women's seed this time. 'I'd be pretty interested to try and see if there is really a difference. If he plays matches in it, then probably there is.'
At the 2024 season-ending ATP Finals last November, Alcaraz said: 'It is something that I'm going to wear more often. I could recover better between points.'
Once associated with Pro Football Hall of Famer Jerry Rice and soccer stars like Cristiano Ronaldo and Neymar, the bands, which essentially look like a Band-Aid worn across the bridge of the nose, are popping up on tennis courts — sometimes out of necessity, sometimes out of curiosity.
They are designed to open the nostrils slightly, making it easier to breathe through the nose. Originally marketed to reduce snoring, they're being embraced to enhance air intake during physical exertion.
The idea is simple: Better breathing could mean better oxygen intake.
In practice, the science is less convincing.
In 2021, Brazilian academic Ricardo Dinardi reviewed more than 600 studies on nasal strips and found they didn't make a real difference in how much air athletes took in, their heart rate or how strenuous exercise felt.
'The effect on athletic performance is mostly placebo,' Dinardi said. 'But in elite sports, even perceived benefits can count.'
Three-time major finalist Casper Ruud, who wore the strips in matches earlier this year, knows the evidence is shaky. But he still liked using them — both on the court and while sleeping. Like Alcaraz, Ruud did not wear one in Paris before his second-round exit.
But he has been testing a prototype of a different version.
'I tried out a device that's very early in development. It will be a bit more comfortable to wear, because it's inside the nose and it looks like I have this bullring under,' said Ruud, who was the runner-up at Roland-Garros to Rafael Nadal in 2022 and Novak Djokovic in 2023. 'It will return, don't worry.'
For other players, like Nicolás Jarry, the strips are more than a trend — they're a necessity. After nasal surgery in 2020, the Chilean still needed help to draw air into his nose, so he puts them on for every practice and every match he plays.
'Without it, I cannot breathe. My nostrils shut when I try,' he said, inhaling to demonstrate for a reporter. 'Others don't have that issue and still use them.'
Jarry definitely has noticed a recent spike in interest among players. He said that even though he's worn the strips for years, including at this French Open, other competitors on tour never asked about them — until Alcaraz started wearing one last year, sometimes in black, sometimes in pink.
'Others have asked me, and many are trying it,' said Jarry, who sported a beige-colored strip in Paris. 'But before him? Nothing.'
There are those, like 2024 US Open runner-up Jessica Pegula, who are tempted to try.
'I have a horrible deviated septum. I can't really breathe out of one side of my nose,' said Pegula, who will play 2023 Wimbledon champion Marketa Vondrousova in the third round Saturday. 'Maybe I should start wearing one.'
She admits, though, that the aesthetic aspect might be a deal-breaker.
'I don't know,' Pegula said with a smile, 'if I have the confidence to rock one.'
___
AP Tennis Writer Howard Fendrich contributed.
___
AP tennis: https://apnews.com/hub/tennis

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Italy gives winning sendoff for Spalletti in World Cup qualifying. De Bruyne saves Belgium
Italy gives winning sendoff for Spalletti in World Cup qualifying. De Bruyne saves Belgium

Washington Post

time3 hours ago

  • Washington Post

Italy gives winning sendoff for Spalletti in World Cup qualifying. De Bruyne saves Belgium

With a parting gift for Luciano Spalletti , Italy beat Moldova 2-0 on Monday for its first points in the beleaguered national team's attempt to reach the World Cup for the first time since 2014. There was also a significant victory in World Cup qualifying for Belgium, with Kevin De Bruyne demonstrating his enduring class by scoring in the 88th minute to snatch a 4-3 win against Wales after his team squandered a 3-0 lead after 27 minutes.

ASCO 2025: Key Highlights in Endometrial and Related Cancers
ASCO 2025: Key Highlights in Endometrial and Related Cancers

Medscape

time5 hours ago

  • Medscape

ASCO 2025: Key Highlights in Endometrial and Related Cancers

Ursula A. Matulonis, MD, shares highlights from several key studies showcasing promising developments in the treatment of endometrial cancer. A phase 2 trial led by Dr Panagiotis Konstantinopoulos evaluated a combination of letrozole, abemaciclib, and metformin in patients with estrogen receptor (ER)-positive recurrent disease, reporting promising results. In the DUO-E trial, a post hoc circulating tumor (ctDNA) analysis demonstrated that durvalumab-based therapy reduced ctDNA levels, particularly in mismatch repair-deficient tumors, with further reductions observed when olaparib was added during maintenance. Additional studies underscored therapeutic innovation: a phase 2 trial of benmelstobart, an anti-programmed death-ligand 1 (PD-L1) antibody, with or without anlotinib in combination with chemotherapy showed high response rates, and HB0025, a bispecific antibody targeting PD-L1 and VEGF, also achieved encouraging preliminary results in first-line treatment. Beyond endometrial cancer, notable progress was reported across other gynecologic malignancies. In cervical cancer, the phase 3 KEYNOTE-A18 trial confirmed the benefit of pembrolizumab plus concurrent chemoradiotherapy, significantly improving both progression-free and overall survival. In vulvar cancer, a phase 2 trial combining pembrolizumab, cisplatin, and radiation therapy showed encouraging antitumor activity. In another phase 2 trial, the HER2-directed antibody-drug conjugate SHR-A1811 demonstrated promising response rates in ovarian, endometrial, and cervical cancers. In ovarian cancer, the FIRST/ENGOT-OV44 trial did not meet its secondary endpoint with the combination of dostarlimab and niraparib maintenance over niraparib alone. However, the ROSELLA trial showed improved overall survival with the combination of relacorilant (a glucocorticoid receptor antagonist) and nab-paclitaxel in platinum-resistant disease.

Arsenal interested in signing Taylor Hinds upon expiration of Liverpool contract
Arsenal interested in signing Taylor Hinds upon expiration of Liverpool contract

New York Times

time5 hours ago

  • New York Times

Arsenal interested in signing Taylor Hinds upon expiration of Liverpool contract

Arsenal are interested in signing Liverpool full-back Taylor Hinds upon the expiration of her contract at the end of this month. Club sources, speaking on the condition of anonymity, said that Liverpool have presented Hinds with a strong contract offer. The 26-year-old Jamaica international was a product of Arsenal's academy and made one appearance for the reigning European champions in 2017 during a 7-0 FA WSL Cup victory over the London Bees. Advertisement Hinds left Arsenal to join Everton in 2018, alongside Chloe Kelly, who is in talks over a new deal with Arsenal after her successful loan from Manchester City. She joined Merseyside rivals Liverpool in 2020. A versatile player capable of playing as a midfielder, full-back and wing-back, Hinds featured in every match for Liverpool in her first two seasons, helping the club return to the Women's Super League in 2022. That year, she signed a new long-term contract in 2022, which is now set to expire on 30 June. Hinds was made vice captain in 2023 under former head coach Matt Beard and has captained the side a number of times. Hinds made 22 Women's Super League appearances for Liverpool last season, scoring two goals as the club finished seventh in the league table following difficult start to the season and the departure of Beard in March. Liverpool have yet to name a full-time manager following Beard's departure. Hinds is one of many players out of contract at Liverpool this summer, including Japan international Fuka Nagano and Wales international Ceri Holland. Arsenal are hoping to bolster their squad ahead of the 2025/26 season as Renee Slegers' side look to compete on multiple fronts. Hinds' versatility and WSL experience makes her an ideal player for cover in defence and the centre of the park. ()

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store